Last year saw a key development in the US respiratory diseases market when Mylan finally launched its generic version of GlaxoSmithKline’s blockbuster inhaler Advair (fluticasone+salmeterol).

Interventions: Patients entered a 4-week, open run-in period, receiving fluticasone propionate 50µg twice daily via a Diskus™ inhalation device. Patients whose asthma was well controlled ...

Subjects were then randomised to receive either an extra inhalation of the same dose ... muscle cramps and headache) and fluticasone propionate-related events (oral candidiasis and hoarseness ...

Seretide (salmeterol xinafoate/fluticasone propionate ... under the Sirdupla brand name and in a pressurised metered dose inhaler (pMDI) device developed by 3M. Like its branded rival ...

After hours: November 22 at 7:58 p.m. EST ...